As of April 2025 Ultragenyx Pharmaceutical has a market cap of HK$23.66 Billion. This makes Ultragenyx Pharmaceutical the world's 3347th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | HK$23.66 B | -23.98% |
2024 | HK$31.12 B | 1.5% |
2023 | HK$30.66 B | 20.85% |
2022 | HK$25.37 B | -43.22% |
2021 | HK$44.69 B | -37.05% |
2020 | HK$70.99 B | 269.02% |
2019 | HK$19.23 B | 11.09% |
2018 | HK$17.31 B | 12.21% |
2017 | HK$15.43 B | -30.73% |
2016 | HK$22.27 B | -34.1% |
2015 | HK$33.80 B | 211.04% |
2014 | HK$10.86 B |
On Apr 6th, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be: